Research Article

Determination of Seroprevalence and Risk Factors of Crimean–Congo Haemorrhagic Fever (CCHF) in the Endemic Region in Turkey: A Population-Based Cross-Sectional Study

Table 5

Logistic regression analysis of some CCHF-related risk factors for anti-CCHFV IgG seropositivity of the participants (n = 2319).

VariablesAnti-CCHFV IgG valueCOR (95% CI)AOR (95% CI)
Seropozitivity n (%)Seronegativity n (%)

LocationUrban70 (5.2)1284 (94.8)0.28Ref.
Rural60 (6.2)905 (93.8)1.22 (0.85–1.74)

FarmingNo93 (4.7)1875 (95.3)<0.001Ref.Ref.
Yes37 (10.5)314 (89.5)2.38 (1.59–3.54) 1.84 (1.18–2.86)

Animal husbandryNo66 (4.3)1485 (95.7)<0.001Ref.Ref.
Yes64 (8.3)704 (91.7)2.05 (1.43–2.92)1.64 (1.04–2.27)

Having a pet at homeNo104 (5.4)1806 (94.6)0.467Ref.
Yes26 (6.4)383 (93.6)1.18 (0.76–1.84)

Tick contact historyNo93 (4.8)1856 (95.2)<0.001Ref.Ref.
Yes37 (10)333 (90)2.22 (1.49–3.30)1.02 (1.03–2.29)

Duration of with tick contact≤1 year15 (12.2)108 (87.8)0.293Ref.
2–4 years13 (11.4)101 (88.6)0.93 (0.42–2.04)
≥5 years9 (6.8)124 (93.2)0.52 (0.22–1.24)

Hospitalization with suspected CCHFNo121 (5.3)2174 (94.7)<0.001Ref.Ref.
Yes9 (37.5)15 (62.5)10.78 (4.62–5.13)6.65 (2.70–16.43)

Is there anyone in your family who was treated for CCHF?No117 (5.4)2040 (94.6)0.165Ref.
Yes13 (8)149 (92)1.52 (0.84–2.77)

If there is anyone in your family who was treated for CCHF, what is the health status? (n = 162)Is alive11 (7.4)138 (92.6)0.308Ref.
Is dead2 (15.4)11 (84.6)2.28 (0.45–11.61)

Is there anyone diagnosed with CCHF where you live?No95 (4.8)1864 (95.2)<0.001Ref.Ref.
Yes35 (9.7)325 (90.3)2.11 (1.41–3.17)1.66 (1.08–2.56)

If there is anyone diagnosed with CCHF where you live, what is the health status? (n = 360)Is alive22 (9.1)220 (90.9)0.563Ref.
Is dead13 (11)105 (89)1.24 (0.60–2.55)

Anti-CCHFV IgG, anti-Crimean–Congo haemorrhagic fever virus immunoglobulin G; COR, crude odds ratio; AOR, adjusted odds ratio; CI, confidence interval; value of Yates’ corrected X2 test for anti-CCHFV IgG serology subgroup comparison.